Business Description
Brii Biosciences Ltd
ISIN : KYG1645A1094
Share Class Description:
BRIBF: Ordinary SharesCompare
Compare
Traded in other countries / regions
02137.Hong KongBRIBF.USA7SS.Germany IPO Date
2021-12-21Description
Brii Biosciences Ltd is a biotechnology company based in China and the United States. It is committed to developing advancing therapies for infectious diseases, such as HBV, HIV, MDR/XDR gram-negative infections, and other illnesses, such as CNS diseases, which have public health burdens in China and worldwide. The company's pipeline of products includes more than 10 product candidates that focus on infectious diseases and mental illnesses.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 843.04 | |||||
| Equity-to-Asset | 0.98 | |||||
| Debt-to-EBITDA | -0.02 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 5.07 | |||||
| Beneish M-Score | 103.06 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 50.8 | |||||
| 3-Year EPS without NRI Growth Rate | 30.7 | |||||
| 3-Year FCF Growth Rate | -12.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 5.32 | |||||
| 9-Day RSI | 4.82 | |||||
| 14-Day RSI | 4.61 | |||||
| 6-1 Month Momentum % | -35.68 | |||||
| 12-1 Month Momentum % | -55.13 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 22.11 | |||||
| Quick Ratio | 22.11 | |||||
| Cash Ratio | 21.14 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.1 | |||||
| Shareholder Yield % | 1.13 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -88269.19 | |||||
| Net Margin % | -28329.63 | |||||
| FCF Margin % | -96565.12 | |||||
| ROE % | -5.51 | |||||
| ROA % | -5.32 | |||||
| ROIC % | -126.75 | |||||
| ROC (Joel Greenblatt) % | -1256.01 | |||||
| ROCE % | -5.88 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1340 | |||||
| PB Ratio | 0.29 | |||||
| Price-to-Tangible-Book | 0.31 | |||||
| EV-to-EBIT | 9.43 | |||||
| EV-to-EBITDA | 10.23 | |||||
| EV-to-Revenue | -2810.03 | |||||
| EV-to-FCF | 2.92 | |||||
| Price-to-Net-Current-Asset-Value | 0.33 | |||||
| Price-to-Net-Cash | 0.35 | |||||
| Earnings Yield (Greenblatt) % | 10.6 | |||||
| FCF Yield % | -66.48 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:BRIBF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Brii Biosciences Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.086 | ||
| EPS (TTM) ($) | -0.033 | ||
| Beta | 0 | ||
| Volatility % | 38.02 | ||
| 14-Day RSI | 4.61 | ||
| 14-Day ATR ($) | 0.002078 | ||
| 20-Day SMA ($) | 0.20177 | ||
| 12-1 Month Momentum % | -55.13 | ||
| 52-Week Range ($) | 0.1667 - 0.5124 | ||
| Shares Outstanding (Mil) | 729.39 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Brii Biosciences Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Brii Biosciences Ltd Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Brii Biosciences Ltd Frequently Asked Questions
What is Brii Biosciences Ltd(BRIBF)'s stock price today?
The current price of BRIBF is $0.18. The 52 week high of BRIBF is $0.51 and 52 week low is $0.17.
When is next earnings date of Brii Biosciences Ltd(BRIBF)?
The next earnings date of Brii Biosciences Ltd(BRIBF) is 2024-08-22 Est..
Does Brii Biosciences Ltd(BRIBF) pay dividends? If so, how much?
Brii Biosciences Ltd(BRIBF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers